Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Orexigen Approval Shows That Diversification Strategy Can Work
Seeking Alpha
Thu, 12/9/10 - 10:55 am
Tags:
Orexigen, FDA, Contrave
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
Tags:
obesity, Orexigen, Vivus, Arena Pharmaceuticals, Contrave, Qnexa
Orexigen Wins U.S. Panel’s Backing for New Diet Pill
Bloomberg Businessweek
Tue, 12/7/10 - 06:05 pm
Tags:
obesity, Orexigen, advisory panels, FDA, Contrave
Orexigen Therapeutics: FDA Panel Live Blog
TheStreet.com
Tue, 12/7/10 - 07:56 am
Tags:
FDA, advisory panels, Orexigen, Contrave, obesity
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Mon, 12/6/10 - 05:04 pm
Tags:
Orexigen, Contrave, FDA, advisory panels, obesity
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
Tags:
GSK, Merck, Avodart, enlarged prostate, prostate cancer, Proscar, Orexigen, obesity, Contrave, Novartis, JNJ, Merck KGaA
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ Online
Fri, 12/3/10 - 11:06 am
Tags:
FDA, obesity, Contrave, hypertension, Orexigen
Orexigen's Diet Pill Has Unclear Benefits, an FDA Staff Review Indicates
Bloomberg
Fri, 12/3/10 - 08:46 am
Tags:
Orexigen, FDA, Contrave, obesity
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
Tags:
FDA, obesity, Orexigen, Contrave, Arena Pharmaceuticals, Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Tags:
Orexigen, options, Contrave, obesity, Vivus, Arena Pharmaceuticals
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Tags:
Delcath, Arena Pharmaceuticals, RXi Pharmaceuticals, Cell Therapeutics, Amgen, Incyte, Celgene, Corcept Therapeutics, Affymax, Targacept, Exelixis, Orexigen, ONYX Pharmaceuticals, Seattle Genetics, MannKind, Alimera, AstraZeneca, Human Genome Sciences
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
Tags:
FDA, advisory panels, Orexigen, Contrave, obesity, Arena Pharmaceuticals, Vivus
Long Odds Seen For Diet Drugs
WSJ Online
Tue, 10/26/10 - 12:37 pm
Tags:
obesity, Arena Pharmaceuticals, Eisai, Orexigen, Contrave
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Tags:
Linjeta, Biodel, Afrezza, MannKind, FDA, Benlysta, Human Genome, GSK, Bydureon, Eli Lilly, Amylin, Alkermes, Brilinta, AstraZeneca, Pradaxa, Boehringer Ingelheim, Qnexa, Vivus, Contrave, Orexigen, ipilimumab, Bristol-Myers Squibb, Merck KGaA, cladribine
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
BNET Pharma
Mon, 10/11/10 - 05:55 pm
Tags:
Meridia, diet drugs, Abbott Laboratories, GSK, Roche, Allergan, Novo Nordisk, Sanofi, Merck, Eli Lilly, Amylin, Takeda, Orexigen
Orexigen Shares Popped: What You Need to Know
Motley Fool
Thu, 10/7/10 - 06:04 pm
Tags:
Orexigen, obesity, Arena Pharmaceuticals, Vivus
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Mon, 09/27/10 - 10:43 am
Tags:
obesity, Vivus, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Biotech Investor Calendar: Obesity Drugs
TheStreet.com
Mon, 09/20/10 - 12:18 pm
Tags:
Vivus, Qnexa, Orexigen, obesity, Contrave, Arena Pharmaceuticals
Arena Pharma: FDA Panel Live Blog
TheStreet.com
Thu, 09/16/10 - 12:18 pm
Tags:
FDA, advisory panels, Arena Pharmaceuticals, obesity, Orexigen, Abbott Laboratories, Contrave, Meridia
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Tags:
Arena Pharmaceuticals, obesity, Takeda, Orexigen, Contrave, Abbott Laboratories, Meridia, Qnexa, Vivus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.